版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
1、Objective To probe the changes and clinical significances of interleukin-13 and interleukin-15 in children with Henoch-Schoenlein purpura(HSP).Methods Plasma IL-13 and IL-15 were detected in 61 children with HSP in acu
2、te phase and 25normal children by ELISA.The level of plasma IL-I 3 and IL-15 in different clinical categories of HSP were compared. Results ①Plasma IL-13 levels in children with HSP in acute phase[ (4.8±3.1) pg/ml]
3、 were significantly higher than those in healthy controls[ (2.0 ±1.6) pg/ml](t=4.28,P<0.01 ); plasma IL-13 levels in patients with or without renal involvement of HSP[ ( 7.5 ± 5.9 ) pg/ml、 ( 3.2 ± 2.5 ) pg/ml] were all s
4、ignificantly higher than those in healthy controls (F=53.92, p<0.01;q=13.87, 3.40, p<0.01 or 0.05 ); the plasma IL-13 levels in patients with renal involvement were significantly higher than those of without renal involv
5、ement (F=53.92, p<0.01 ;q= 11.86, p<0.01 ).②Also,plasma IL-15 levels of HSP group[ ( 17.5 ± 10.2) pg/ml] are significantly higher than those of controls[ ( 4.2± 3.5 ) pg/ml] (t=6.34, P<0.01 ); both plasma IL-15 levels wi
6、th and without renal involvement[ (29.1± 16.5)pg/ml、 (10.5±7.4) pg/ml] were significantly higher than those in healthy controls(F=40.45, p<0.01;q=12.18, 3.46, p<0.01); the plasma IL-15 levels in patients with renal invol
7、vement were significantly higher than those of without renal involvement (F= 4 0.4 5, p<0.01;q= 9.9 5, p<0.01 ). Conclusions Plasma IL-13 and IL-15 levels in acute phase of HSP significantly increased, and the levels
8、 in patients with renal involvement were significantly higher than those of without renal involvement. These results suggested that IL-13 and IL-15 play a crucial role in pathogenesis of HSP. The plasma IL-13 and IL-15 l
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 眾賞文庫(kù)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 過敏性紫癜患兒血漿白細(xì)胞介素33水平變化及意義初步探討.pdf
- 過敏性紫癜患兒血漿白細(xì)胞介素9水平變化及意義初步探討.pdf
- 過敏性紫癜患兒血清白細(xì)胞介素-10、-13、-15的水平變化及意義.pdf
- 白細(xì)胞介素17表達(dá)水平與兒童過敏性紫癜復(fù)發(fā)的關(guān)系.pdf
- 兒童過敏性紫癜急性期血漿MPO、MDA、SOD及T-AOC水平變化及臨床意義.pdf
- 過敏性紫癜患兒血漿IL-22水平變化及意義探討.pdf
- 兒童過敏性紫癜急性期免疫狀態(tài)的研究.pdf
- FOXP3在兒童過敏性紫癜急性期的表達(dá).pdf
- 過敏性紫癜急性期患兒血清Il-17、MMP-9的變化及意義.pdf
- 兒童過敏性紫癜
- 兒童過敏性紫癜急性期凝血狀態(tài)與腎臟損傷的關(guān)系.pdf
- 兒童過敏性紫癜急性期Th17細(xì)胞功能與CD4+CD25+調(diào)節(jié)性T細(xì)胞水平變化.pdf
- 過敏性紫癜急性期血漿可溶性細(xì)胞間粘附分子-1和血管內(nèi)皮生長(zhǎng)因子水平的變化及意義探討.pdf
- 兒童過敏性紫癜血漿及尿中內(nèi)皮素水平的臨床研究.pdf
- 急性期過敏性紫癜患兒免疫功能的初步研究.pdf
- 過敏性紫癜急性期輔助性T細(xì)胞亞群變化和血漿轉(zhuǎn)化生長(zhǎng)因子-β-,1-水平研究.pdf
- COPD急性加重期患者血漿白細(xì)胞介素18、γ-干擾素的變化及意義.pdf
- 白細(xì)胞介素17、白細(xì)胞介素8在COPD患者血漿中的變化及意義.pdf
- 兒童過敏性紫癜血清低糖基化IgAl水平變化及意義.pdf
- AngⅡ的水平變化在兒童過敏性紫癜中的臨床意義.pdf
評(píng)論
0/150
提交評(píng)論